Differences in susceptibility to colonic stem cell somatic mutation in three strains of mice
- 1 April 2001
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 193 (4), 517-521
- https://doi.org/10.1002/path.834
Abstract
Different species and different strains of animals commonly show very different sensitivities to carcinogenic regimes, which are often unexplained. A major possible contributory factor is variation in susceptibility to mutation, but this has not been directly demonstrated. This study therefore quantified the colonic stem cell mutation frequency in three strains of mice using two carcinogens. Stem cell mutations were identified using loss of function of glucose 6‐phosphate dehydrogenase (G6PD) in individual crypts, a technique validated by several previous studies. The carcinogens dimethylhydrazine (DMH) and ethyl nitrosurea (ENU) were given to Balb/C, C57BL/6J, and C3H mice. In response to DMH, Balb/C mice were most susceptible, with approximately double the stem cell mutation frequency found in C3H and more than ten‐fold that found in C57BL/6J (3.3±0.71 vs. 1.5±0.52 vs. 0.28±0.8×10−4). In response to ENU, Balb/C mice and C3H mice were equally susceptible, showing a stem cell mutation frequency approximately twice that of C57BL/6J (3.1±0.4 vs. 3.1±0.65 vs. 1.63±0.28×10−4). The observed differences among the strains with respect to somatic mutation following DMH treatment are likely to be due to the previously documented differences in metabolic conversion to the active metabolite. However, as ENU is a directly acting, rapidly inactivated mutagen, strain differences in response to ENU are unlikely to be due to strain‐dependent metabolism of the mutagen and are likely to reflect differences in DNA repair efficiency, or possibly in stem cell kinetics among the strains studied. Susceptibility to the induction of colonic stem cell mutation is an important factor in susceptibility to carcinogens, whether due to differences in DNA repair or to other factors. Direct quantification of stem cell mutation frequency allows the separate identification of this component of the carcinogenic cascade and shows that it can make a major contribution to the differing susceptibility of different mouse strains. Copyright © 2001 John Wiley & Sons, Ltd.Keywords
This publication has 24 references indexed in Scilit:
- Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DMA mismatch repairNature Genetics, 1998
- Gene interaction and single gene effects in colon tumour susceptibility in miceNature Genetics, 1996
- Normal colonic mucosa in hereditary non-polyposis colorectal cancer shows no generalised increase in somatic mutationBritish Journal of Cancer, 1995
- A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors.Proceedings of the National Academy of Sciences, 1994
- Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouseCell, 1993
- A review of the genotoxicity of 1-ethyl-1-nitrosoureaMutation Research/Reviews in Genetic Toxicology, 1993
- Multiple Intestinal Neoplasia Caused by a Mutation in the Murine Homolog of the APC GeneScience, 1992
- Crypt restricted heterogeneity of goblet cell mucus glycoprotein in histologically normal human colonic mucosa: a potential marker of somatic mutationBritish Journal of Cancer, 1990
- Alkylation of deoxyribonucleic acid in vivo in various organs of C57BL mice by the carcinogens N-methyl-N-nitrosourea, N-ethyl-N-nitrosourea and ethyl methanesulphonate in relation to induction of thymic lymphoma. Some applications of high-pressure liquid chromatographyBiochemical Journal, 1978
- The multipotential carcinogenic action of N-ethyl-N-nitrosourea administered neonatally to miceBritish Journal of Cancer, 1976